A2 Biotherapeutics Inc.
Clinical trials sponsored by A2 Biotherapeutics Inc., explained in plain language.
-
Smart immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called A2B395 for adults with advanced solid tumors (like colorectal, lung, or breast cancer) that have not responded to other therapies. The treatment uses specially engineered immune cells designed to kill cancer cells while leaving healthy cell…
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Jun 18, 2026 11:48 UTC
-
Smart immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment using a patient's own immune cells, called CAR T cells, that are specially designed to target and kill solid tumor cells while leaving healthy cells unharmed. It is for adults with certain advanced cancers, including lung, colon, pancreatic, ovari…
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
Scientists gather key materials to create personalized cell therapies for Hard-to-Treat cancers
Knowledge-focused Recruiting nowThis study collects tumor tissue and blood cells from 200 adults with advanced solid tumors like colorectal, lung, or pancreatic cancer. The goal is to understand which cancers might respond to a future CAR T-cell therapy and to store participants' own immune cells for potential …
Sponsor: A2 Biotherapeutics Inc. • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC